Aptamers are short DNA, RNA, or peptide

structures that have enormous therapeutic

potential, because they possess the ability to

​target molecules and proteins for which 

antibodies are not well suited with

equally high specificity and affinity​.

These structures can be used as synthetic

antibodies and act as supplements to reach

previously untouched areas of therapeutics.

Aptamers recognize virtually an ​unlimited spectrum of molecular targets​, unbound by limitations of immunogenicity. Because aptamers are generated chemically,  precise control can be exercised over their synthesis, purity and pharmokinetic profile. These combined properties enable aptamers to be rightfully named as cutting edge therapeutic tools to treat disease into the 21st century.​​